Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease
- PMID: 19687424
- PMCID: PMC8375560
- DOI: 10.1001/archdermatol.2009.78
Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease
Abstract
Background: Sclerotic-type chronic graft-vs-host disease (cGVHD) of the skin is an uncommon but potentially debilitating sequela of allogeneic hematopoietic stem cell transplantation. There is no standardized assessment measure for this form of cGVHD. Because a full-thickness incisional biopsy specimen to the level of the fascia may be needed to make a definitive histologic diagnosis of cGVHD-related fasciitis, a noninvasive technique for the assessment and monitoring of sclerotic-type cGVHD, particularly cGVHD-related fasciitis, would be of potential value.
Observations: Sixty-two consecutive patients with cGVHD following allogeneic hematopoietic stem cell transplantation were evaluated for sclerotic skin disease. Forty-four patients (71%) had cutaneous cGVHD, and 28 patients (45%) had evidence of sclerotic involvement based on physical examination findings. Fifteen patients agreed to undergo research magnetic resonance imaging to evaluate quantifiable changes in the dermis, subcutaneous tissue, and muscle. Among 15 patients, magnetic resonance imaging identified abnormalities in the skin in 7 (47%), subcutaneous fibrous septa in 13 (87%), deep fascia in 12 (80%), epimysium in 9 (60%), and muscle in 3 (20%).
Conclusions: Magnetic resonance imaging should be considered in the evaluation of patients with cGVHD suspected of having subcutaneous or fascial involvement. Additional studies are needed to validate this noninvasive modality for serial monitoring of disease activity and response to therapy. Trial Registration clinicaltrials.gov Identifier: NCT00331968.
Figures


Similar articles
-
Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.Acta Derm Venereol. 2018 Feb 7;98(2):206-211. doi: 10.2340/00015555-2824. Acta Derm Venereol. 2018. PMID: 29057425
-
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.Adv Rheumatol. 2022 Aug 23;62(1):33. doi: 10.1186/s42358-022-00262-3. Adv Rheumatol. 2022. PMID: 35999577 Review.
-
Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.Br J Dermatol. 2014 Jul;171(1):63-8. doi: 10.1111/bjd.12828. Epub 2014 Jun 24. Br J Dermatol. 2014. PMID: 24404963
-
Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.JAMA Dermatol. 2019 Jul 1;155(7):833-837. doi: 10.1001/jamadermatol.2018.5459. JAMA Dermatol. 2019. PMID: 30994873 Free PMC article.
-
Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case.J Clin Rheumatol. 2015 Mar;21(2):86-94. doi: 10.1097/RHU.0000000000000212. J Clin Rheumatol. 2015. PMID: 25710860 Review.
Cited by
-
Classification systems for chronic graft-versus-host disease.Blood. 2017 Jan 5;129(1):30-37. doi: 10.1182/blood-2016-07-686642. Epub 2016 Nov 7. Blood. 2017. PMID: 27821503 Free PMC article. Review.
-
Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study.Bone Marrow Transplant. 2019 Apr;54(4):616-619. doi: 10.1038/s41409-018-0346-7. Epub 2018 Oct 4. Bone Marrow Transplant. 2019. PMID: 30287938 Free PMC article. No abstract available.
-
Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.J Am Acad Dermatol. 2012 Apr;66(4):515.e1-18; quiz 533-4. doi: 10.1016/j.jaad.2011.11.960. J Am Acad Dermatol. 2012. PMID: 22421123 Free PMC article.
-
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.Transplant Cell Ther. 2025 Feb;31(2):69.e1-69.e18. doi: 10.1016/j.jtct.2024.12.011. Epub 2024 Dec 17. Transplant Cell Ther. 2025. PMID: 39701289
-
Optical Coherence Tomography for Quantifying Human Cutaneous Chronic Graft-versus-Host Disease.Transplant Cell Ther. 2021 Mar;27(3):271.e1-271.e8. doi: 10.1016/j.jtct.2020.11.023. Epub 2020 Dec 16. Transplant Cell Ther. 2021. PMID: 33781538 Free PMC article.
References
-
- Filipovich AH, Weisdorf D, Pavletic S, et al.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease, I: Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2005;11(12):945–956. - PubMed
-
- Hymes SR, Turner ML, Champlin RE, Couriel DR. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006;12(11):1101–1113. - PubMed
-
- Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol. 2005;53(4):591–601. - PubMed
-
- Häusermann P, Walter RB, Halter J, et al.Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology. 2008;216(4):287–304. - PubMed
-
- Kimball AB, Summers RM, Turner M, et al.Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy. Arthritis Rheum. 2000;43(8):1866–1873. - PubMed